Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides

Environmental Health and Preventive Medicine

Volumn 22, Issue 1, 2017, Pages

  Di Lodovico, Silvia ^a   Cataldi, Valentina ^a   Di Campli, Emanuela ^a   Ancarani, Elisabetta ^a   Cellini, Luigina ^a   Di Giulio, Mara ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Biocidal products; Biofilm; Enterococcus hirae; Hospital acquired infections (HAIs); Sanitation

Indexed keywords

BIOCIDE; POLYSTYRENE; STAINLESS STEEL; CONCANAVALIN A; DISINFECTANT AGENT; POLYSTYRENE DERIVATIVE;

ARTICLE; BIOFILM; BIOMASS; CELL VIABILITY; ENTEROCOCCUS HIRAE; NONHUMAN; SURFACE PROPERTY; TEMPERATURE; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HOSPITAL EQUIPMENT; HUMAN; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGY; PHYSIOLOGY;

BIOFILMS; CONCANAVALIN A; CROSS INFECTION; DISINFECTANTS; ENTEROCOCCUS HIRAE; EQUIPMENT AND SUPPLIES, HOSPITAL; EQUIPMENT CONTAMINATION; HUMANS; POLYSTYRENES; STAINLESS STEEL;

EID: 85031745305     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1186/s12199-017-0670-3     Document Type: Article

References (33)

1. Sahu MK, Siddharth B, Choudhury A, Vishnubhatla S, Singh SP, Menon R, et al. Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit. Ann Card Anaesth. 2016;19:281-7.
2. European Centre for Disease Prevention and Control (ECDPC). Annual epidemiological report 2014--antimicrobial resistance and healthcareassociated infections. Available at: https://ecdc.europa.eu/sites/portal/files/ media/en/publications/Publications/antimicrobial-resistance-annualepidemiological-report.pdf.
3. Emily RM, Sydnor TM. Hospital epidemiology and infection control in acutecare settings. Clin Microbiol Rev. 2011;24(1):141-73.
4. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013;26(4):338-44.
5. de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol. 2013;16(5):580-9.
6. Gomes LC, Silva LN, Simões M, Melo LF, Mergulhão FJ. Escherichia coli adhesion, biofilm development and antibiotic susceptibility on biomedical materials. J Biomed Mater Res A. 2015;103(4):1414-23.
7. Abreu AC, Tavares RR, Borges A, Mergulhao F, Simoes M. Current and emergent strategies for disinfection of hospital environments. J Antimicrob Chemother. 2013;68(12):2718-32.
8. Cataldi V, Di Bartolomeo S, Di Campli E, Nostro A, Cellini L, Di Giulio M. In vitro activity of Aloe vera inner gel against micro-organisms grown in planktonic and sessile phases. Int J Immunopathol Pharmacol. 2015;28(4):595-602.
9. Sepehr S, Rahmani-Badi A, Babaie-Naiej H, Soudi MR. Unsaturated fatty acid, cis-2-decenoic acid, in combination with disinfectants or antibiotics removes pre-established biofilms formed by food-related bacteria. PLoS One. 2014;9:e101677.
10. Collins AS. Patient safety and quality: an evidence-based handbook for nurses. In: Preventing health care-associated infections; 2008. Chapter 41.
11. Rutala WA, Weber DJ. Disinfectants used for environmental disinfection and new room decontamination technology. Am J Infect Control. 2013;41(5 Suppl):S36-41.
12. Rutala WA, Weber DJ. Disinfection and sterilization: an overview. Am J Infect Control. 2013;41(5 Suppl):S2-5.
13. Biocides Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market.
14. Paganelli FL, Willems RJ, Leavis HL. Optimizing future treatment of enterococcal infections: attacking the biofilm? Trends Microbiol. 2012;20(1):40-9.
15. EN 14561:2006 Chemical disinfectants and antiseptics. Quantitative carrier test for the evaluation of bactericidal activity for instruments used in the medical area. Test method and requirements (phase 2, step 2).
16. Bourafa N, Loucif L, Boutefnouchet N, Rolain JM. Enterococcus hirae, an unusual pathogen in humans causing urinary tract infection in a patient with benign prostatic hyperplasia: first case report in Algeria. New Microbes New Infect. 2015;17:7-9.
17. Talarmin JP, Pineau S, Guillouzouic A, Boutoille D, Giraudeau C, Reynaud A, et al. Relapse of Enterococcus hirae prosthetic valve endocarditis. J Clin Microbiol. 2011;49(3):1182-4.
18. Pãosinho A, Azevedo T, Alves JV, Costa IA, Carvalho G, Peres SR, et al. Acute pyelonephritis with bacteremia caused by Enterococcus hirae: a rare infection in humans. Case Rep Infect Dis. 2016;2016:4698462. doi:10.1155/2016/4698462.
19. Poyart C, Lambert T, Morand P, Abassade P, Quesne G, Baudouy Y, et al. Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol. 2002; 40(7):2689-90.
20. Vinh DC, Nichol KA, Rand F, Embil JM. Native-valve bacterial endocarditis caused by Lactococcus garvieae. Diagn Microbiol Infect Dis. 2006;56(1):91-4.
21. Dicpinigaitis PV, De Aguirre M, Divito J. Enterococcus hirae bacteremia associated with acute pancreatitis and septic shock. Case Rep Infect Dis. 2015;2015:123852. doi:10.1155/2015/123852.
22. Sim JS, Kim HS, Oh KJ, Park MS, Jung EJ, Jung YJ, et al. Spontaneous bacterial peritonitis with sepsis caused by Enterococcus hirae. J Korean Med Sci. 2012;27(12):1598-600.
23. Brulé N, Corvec S, Villers D, Guitton C, Bretonnière C. Life-threatening bacteremia and pyonephrosis caused by Enterococcus hirae. Med Mal Infect. 2013;43(9):401-2.
24. Di Giulio M, di Giacomo V, Di Campli E, Di Bartolomeo S, Zara S, Pasquantonio G, et al. Saliva improves Streptococcus mitis protective effect on human gingival fibroblasts in presence of 2-hydroxyethyl-methacrylate. J Mater Sci Mater Med. 2013;24(8):1977-83.
25. Baldassarri L, Cecchini R, Bertuccini L, Ammendolia MG, Iosi F, Arciola CR, et al. Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol. 2001;190(3):113-20.
26. Parizzi SQF, Andrade NJ, Silva AS, Soares NFFS, Silva AM. Bacterial adherence to different inert surfaces evaluated by epifluorescence microscopy and plate count method. Braz Arch Biol Technol. 2004;47:77-83.
27. Di Giulio M, Traini T, Sinjari B, Nostro A, Caputi S and Cellini L. Porphyromonas gingivalis biofilm formation in different titanium surfaces, an in vitro study. Clin Oral Implants Res 2015; doi: 10.1111/clr.12659.
28. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175-9.
29. Arnold JW, Bailey GW. Surface finishes on stainless steel reduce bacterial attachment and early biofilm formation: scanning electron and atomic force microscopy study. Poult Sci. 2000;79(12):1839-45.
30. Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(Pt 6):1749-57.
31. Van Wamel WJ, Hendrickx AP, Bonten MJ, Top J, Posthuma G, Willems RJ. Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation. Infect Immun. 2007;75(2):924-31.
32. Lleo M, Bonato B, Tafi MC, Caburlotto G, Benedetti D, Canepari P. Adhesion to medical device materials and biofilm formation capability of some species of enterococci in different physiological states. FEMS Microbiol Lett. 2007;274(2):232-7.
33. Rizzotti L, Rossi F, Torriani S. Biocide and antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from the swine meat chain. Food Microbiol. 2016;60:160-4.